Skip to main
BOLD
BOLD logo

BOLD Stock Forecast & Price Target

BOLD Analyst Ratings

Based on 15 analyst ratings
Hold
Strong Buy 20%
Buy 33%
Hold 33%
Sell 7%
Strong Sell 7%
BOLD has been analyzed by 15 analysts, with a consensus rating of Hold. 20% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 7% advise Selling, and 7% predict a Strong Sell.

This aggregate rating is based on analysts' research of Boundless Bio Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Boundless Bio Inc (BOLD) Forecast

Analysts have given BOLD a Hold based on their latest research and market trends.

According to 15 analysts, BOLD has a Hold consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $33.07, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $33.07, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Boundless Bio Inc (BOLD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.